Citation
Bohl, D, et al. "A Clinical Trial Comparing a New NSAID (droxicam) and Piroxicam in Spinal Osteoarthritis." International Journal of Clinical Pharmacology, Therapy, and Toxicology, vol. 28, no. 10, 1990, pp. 416-9.
Bohl D, Gausmann H, Vorberg G, et al. A clinical trial comparing a new NSAID (droxicam) and piroxicam in spinal osteoarthritis. Int J Clin Pharmacol Ther Toxicol. 1990;28(10):416-9.
Bohl, D., Gausmann, H., Vorberg, G., Sánchez, J., García-Barbal, R., Sarti, J. F., & Harrison, F. J. (1990). A clinical trial comparing a new NSAID (droxicam) and piroxicam in spinal osteoarthritis. International Journal of Clinical Pharmacology, Therapy, and Toxicology, 28(10), 416-9.
Bohl D, et al. A Clinical Trial Comparing a New NSAID (droxicam) and Piroxicam in Spinal Osteoarthritis. Int J Clin Pharmacol Ther Toxicol. 1990;28(10):416-9. PubMed PMID: 2258250.
TY - JOUR
T1 - A clinical trial comparing a new NSAID (droxicam) and piroxicam in spinal osteoarthritis.
AU - Bohl,D,
AU - Gausmann,H,
AU - Vorberg,G,
AU - Sánchez,J,
AU - García-Barbal,R,
AU - Sarti,J F,
AU - Harrison,F J,
PY - 1990/10/1/pubmed
PY - 1990/10/1/medline
PY - 1990/10/1/entrez
SP - 416
EP - 9
JF - International journal of clinical pharmacology, therapy, and toxicology
JO - Int J Clin Pharmacol Ther Toxicol
VL - 28
IS - 10
N2 - This double-blind, parallel, controlled and randomized trial compares the clinical efficacy and tolerance of a new NSAID (pro-drug of piroxicam), droxicam, at the dose of 20 mg/day against that of piroxicam at the same dose. The comparison is drawn after the administration to 30 patients with spinal osteoarthritis during 8 weeks after a single-blind placebo-period run-in of 7 days. Results show that both drugs improve, with statistical significance, all parameters evaluated (pain intensity, morning stiffness, nocturnal pain, pain after getting up and after 30 min standing, difficulty in daily living, frequency of pain exacerbations and the ability to do several daily activities). No statistically significant differences were found between groups. Only one case in the droxicam group and two in the piroxicam group reported subjective complaints of mild intensity that did not require additional treatment or interruption of the study.
SN - 0174-4879
UR - https://www.unboundmedicine.com/medline/citation/2258250/A_clinical_trial_comparing_a_new_NSAID__droxicam__and_piroxicam_in_spinal_osteoarthritis_
L2 - https://medlineplus.gov/osteoarthritis.html
DB - PRIME
DP - Unbound Medicine
ER -